BNAI
Brand Engagement NetworkBAI scenario view
RankAlpha Sentiment CodexThe current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
Primary-source evidence is strong, but forward visibility is limited by low coverage, preliminary acquisition disclosures, and absent social/options data. The deterministic signal is negative despite strategic expansion; this is best treated as a monitoring setup pending consolidated post-acquisition results.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
An August 28 8-K reported aggregate cash proceeds of $259,125.60. The excerpt does not establish the terms, use of proceeds, or funding sufficiency, making this a weak near-term signal rather than a confirmed operating catalyst. [#8-K-2026-08-28]
BNAI reported that the acquired Cataneo operations generated approximately $5.3 million of first-half 2026 revenue and that it expects approximately $900,000 of annualized cost synergies. The figures were preliminary and unaudited, and the acquisition closed on June 30, so future filings must validate consolidation, margins, and integration progress. [#SEC-8K-2026-07-27]
The company disclosed the Cataneo acquisition, a 50/50 health-AI joint venture, and a strategic investment in Accelevate. These initiatives broaden the commercial footprint, but monetization and execution remain unproven. [#SEC-8K-2026-08-14]
Recommendation
No formal recommendation provided.

